Cargando…
Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China
Autores principales: | Zhao, Liang, Du, Hongyao, Alamgir, Mahin, Yang, Jing, Miao, Xiaoping, Jiang, Biling, Xia, Yuting, Lou, Yuchen, Wang, Yujue, Shen, Chen, Zhu, Jinjin, Chung, Wen-Hung, Li, Yan, Tao, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Libbey Eurotext
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880659/ https://www.ncbi.nlm.nih.gov/pubmed/33459264 http://dx.doi.org/10.1684/ejd.2020.3908 |
Ejemplares similares
-
Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
por: Chang, Tianli, et al.
Publicado: (2021) -
Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
por: Cavalcante, Marcelo Borges, et al.
Publicado: (2020) -
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China
por: Liu, Weiyong, et al.
Publicado: (2020) -
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
por: Chen, Lian, et al.
Publicado: (2020) -
Clinical data of early COVID-19 cases receiving extracorporeal membrane oxygenation in Wuhan, China
por: Huang, Shiqian, et al.
Publicado: (2021)